What Happened?
London, ON-based Avail-Scientific Promoted Gerard Maynard as Chief Revenue Officer
About the Company
Avail Scientific is working to facilitate a medical and social revolution of the current pharmacological therapies for addiction and the underlying causes by providing evidence-based diagnostic and data acquisition programs. These substances can be used as both treatment for addiction and as preventative therapy by addressing the health challenges underlying substance abuse. We are building a platform to both educate and equip healthcare professionals with the data to use these therapeutic tools efficiently. Our objective is to treat this medical condition and prove out rehabilitation and preventative therapy programs with our partners in healthcare communities, both local and globally. Avail Scientific is positioned to become a global leader in eliminating the needless suffering that surrounds addiction and mental health issues by providing effective data and patient monitoring to validate their efficacy.
About the Person
Gerard Maynard is Chief Revenue Officer at Avail Scientific. Previously, Gerard held various senior HR leadership roles in the industry.
Info Source
News
Short Profile